For the quarter ending 2025-09-30.
| Income Statement | 2025-09-30 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| General and administrative expenses | 4,320 | 4,557 | 3,181 | |
| Professional fees | 23,975 | 32,293 | 8,545 | |
| Salaries and wages | 182,839 | 46,838 | 46,145 | |
| Total operating expenses | 211,134 | 83,688 | 57,871 | |
| Loss from operations | -211,134 | -83,688 | -57,871 | |
| Loss on derivative | 3,425,796 | - | - | |
| Unrealized gain (loss) on available for sale securities | -24,978 | - | - | |
| Interest expense (includes amortization of debt discount) | 60,857 | 61,403 | 56,912 | |
| Unrealized gain (loss) on available for sale securities | - | -47,746 | 14,083 | |
| Gain (loss) on change in derivative liability | 128,101 | - | - | |
| Total other (expense) | -3,383,530 | -109,149 | -42,829 | |
| Net loss | -3,594,664 | -192,837 | -100,700 | |
| Basic EPS | -0.16 | -0.01 | 0 | |
| Diluted EPS | -0.16 | -0.01 | 0 | |
| Basic Average Shares | 22,004,764 | 21,674,000 | 21,674,000 | |
| Diluted Average Shares | 22,004,764 | 21,674,000 | 21,674,000 | |
Balance Labs, Inc. (BLNC)
Balance Labs, Inc. (BLNC)